9 Meters Biopharma Inc

NASDAQ:NMTR  
0.27
+0.01 (+3.53%)
Debt Financing / Related

9 Meters Biopharma Entered Into Securities Purchase Agreement For Purchase Of Senior Secured Convertible Notes With Institutional Investor

Published: 06/30/2022 12:39 GMT
9 Meters Biopharma Inc (NMTR) - 9 Meters Biopharma-on June 30, Entered Into Securities Purchase Agreement for Purchase of Senior Secured Convertible Notes With Institutional Investor.
9 Meters Biopharma- Principal Amount for Initial Note is Expected to Be $21 Million With Option to Issue Additional Convertible Notes of Up to $70 Million.
9 Meters Biopharma Inc - Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome.
9 Meters Biopharma Inc - Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel Syndrome.
Further Company Coverage: Nmtro